CorMedix, Inc. (CRMD)
7.905
-0.14
(-1.80%)
USD |
NASDAQ |
May 07, 14:32
CorMedix Cash from Investing (Quarterly) : 3.297M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | 785.00M |
| Altimmune, Inc. | -79.16M |
| Theravance Biopharma, Inc. | 0.588M |
| REGENXBIO, Inc. | 37.54M |
| Janux Therapeutics, Inc. | 29.54M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 94.46M |
| Cash from Financing (Quarterly) | -1.413M |
| Free Cash Flow | 172.79M |
| Free Cash Flow Per Share (Quarterly) | 0.9875 |
| Free Cash Flow to Equity (Quarterly) | -51.78M |
| Free Cash Flow to Firm (Quarterly) | 93.19M |
| Free Cash Flow Yield | 27.23% |